Stay updated with breaking news from Saran saund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oncotelic Therapeutics and Vectara Announce Strategic Partnership to Transform Pharmaceutical Research with Large Language Model Technology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Oncotelic Therapeutics (OTCQB:OTLC) Chief Business Officer Saran Saund talks to Proactive about the Agoura Hills, California-based group s recent joint. ....
Clinical trials have demonstrated that intermittent apomorphine injections provide rapid and effective relief from sudden, unexpected “off” periods brought on by primary Parkinson’s medicine, levodopa. ....
The product, PulmoHeal™ is a broad-spectrum, lung therapy food supplement that is supported by a multi-centre rigorous clinical study and integrated with its own telemedicine AI based platform to offer continuous 360 care for patients in India. Developed from extract of the indigenous plant Artemisia, the active component of PulmoHealTM, Artemisinin, has been known to exhibit multiple pharmacological activity against inflammation, viral infections, and lung repair ....
Press release content from Globe Newswire. The AP news staff was not involved in its creation. MATEON PARTNERED WITH CHOPRA FOUNDATION ON ARTIVEDA™ Mateon Therapeutics, Inc.February 16, 2021 GMT AGOURA HILLS, California, Feb. 16, 2021 (GLOBE NEWSWIRE) Mateon Therapeutics, Inc. (OTCQB:MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and infectious disease and respiratory health, announced a global partnership with Chopra Foundation, a non-profit, to collaborate on research and development of PulmoHeal™ and ARTIVeda™ for COVID-19 and other infectious diseases through joint research between Mateon and Foundation Principal Investigators (PI) from premium US universities. “We view this collaboration as a cornerstone for the future development of the ARTIVeda™ and PulmoHeal™ brands to make a significant impact on the development of ethnobiology drugs for the treatment of emerging diseases.” said Saran Saund, CBO and GM of A ....